Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1994-09-01
1999-09-21
Huff, Sheela
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 723, 436 63, 436 64, 536 231, 536 241, C12Q 168, G01N 33574, G01N 3348, C07H 2102
Patent
active
059552638
ABSTRACT:
Specific sequences in the human genome are the sites of strong binding of wild-type p53 protein, but not mutant forms of the protein. These sequences are used diagnostically to detect cells in which the amount of wild-type p53 is diminished. The sequences can also be used to screen for agents which correct for loss of wild-type p53 to DNA in cancer cells.
REFERENCES:
Kern et al., "Oncogenic Forms of p53 Inhibit p53-Regulated Gene Expressions", Science 256:827-830 (1992).
El-Deiry et al., "Definition of a Conseusus Binding Site for p53", Nature Genetics 1:45-49 (1992).
Bargonetti et al., "Wild-Type But Not Mutant p53 Immunopurified Proteins Bind to Sequences Adjacent to the SV40 Origin of Replication," Cell 65:1-9 (1991).
Jelinek et al., "Ubiquitous, Interspersed Repeated Sequences in Mammalian Genomes", Proc. Natl. Acad. Sci. USA, 77(3):1398-1402 (1980).
Mercer et al., "Negative Growth Regulation in a Gliblastoma Tumor Cell Line That Conditionally Expresses Human Wild-Type p53", Proc. Natl. Acad. Sci. USA 87:6166-6170 (1990).
Diller et al., "p53 Functions as a Cell Cycle Control Protein in Osteosarcomas", Molecular and Cellular Biology10(11):5772-5781 (1990).
Baker et al., "Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53", Science 249:912-915 (1990).
Kern et al., "Mutant p53 Proteins Bind DNA Abnormally in vitro ", Oncogene 6(1):131-136 (1990).
Finlay et al., "The p53 Proto-Oncogene Can Act As a Suppressor of Transformation", Cells 57:1083-1093 (1989).
Romano et al., "Identification and Characterization of a p53 Gene Mutation in a Human Osteosarcoma Cell Line", Oncogene 4:1483-1488 (1989).
Yewdell et al., "Monoclonal Antibody Analysis of p53 Expression in Normal and Transformed Cells", Journal of Virology 59(2):444-452 (1986).
Nigro et al., "Mutations in the p53 Gene Occur in Diverse Human Tumor Types", Nature 342:705-708 (1989).
Eliyahu et al., "Wild-type p53 Can Inhibit Oncogene-Mediated Focus Formation", Proc. Natl. Acad. Sci. USA 86:8763-8767 (1989).
Weintraub et al., "Activation of Muscle-Specific Genes in Pigment, Nerve, Fat, Liver, and Fibroblast Cell Lines by Forced Expression of MyoD", Proc. Natl. Acad. Sci. USA 86:5434-5438 (1989).
Weintraub et al., "The MCK Enhancer Contains a p53 Responsive Element", Proc. Natl. Acad. Sci. USA, 88:4570-4571 (1991).
Zambetti et al., "Wild-type p53 Mediates Positive Regulation of Gene Expression Through a Specific DNA Sequence Element", Genes & Development 6:1143-1152 (1992).
Baker et al., "Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas", Science, 244:217-221 (1989).
Kinzler Kenneth W.
Sherman Michael I.
Vogelstein Bert
Eyler Yvonne
Genzyme Corporation
Huff Sheela
Johns Hopkins University
LandOfFree
Sequence specific DNA binding by p53 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sequence specific DNA binding by p53, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sequence specific DNA binding by p53 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-78899